This combined analysis revealed a highly significant three-fold increased risk of fibrosis following radiotherapy if a breast cancer patient carries at least one variant TGFβ1 (−509T) allele (P=0.00006) and this applies to over 50% of breast cancer patients. The gene discussed is TGFB1; the disease is breast cancer.